Royce & Associates LP Takes $9.62 Million Position in Maximus, Inc. $MMS

Royce & Associates LP acquired a new stake in shares of Maximus, Inc. (NYSE:MMS) during the 4th quarter, HoldingsChannel reports. The institutional investor acquired 111,410 shares of the health services provider’s stock, valued at approximately $9,617,000.

Several other hedge funds have also recently modified their holdings of the stock. Richardson Financial Services Inc. increased its holdings in shares of Maximus by 29.6% during the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after acquiring an additional 103 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after purchasing an additional 116 shares during the last quarter. Arizona State Retirement System raised its stake in shares of Maximus by 0.9% in the third quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock worth $1,524,000 after purchasing an additional 156 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Maximus by 13.8% in the fourth quarter. GAMMA Investing LLC now owns 1,522 shares of the health services provider’s stock worth $131,000 after purchasing an additional 185 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Trading Up 1.3%

Shares of NYSE:MMS opened at $62.84 on Friday. Maximus, Inc. has a 52-week low of $56.92 and a 52-week high of $100.00. The stock has a market cap of $3.30 billion, a price-to-earnings ratio of 9.41 and a beta of 0.60. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. The business has a 50-day moving average price of $64.65 and a 200-day moving average price of $77.43.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same period last year, the business posted $2.01 earnings per share. The company’s revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities analysts predict that Maximus, Inc. will post 8.43 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.1%. Maximus’s payout ratio is currently 19.76%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Finally, Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Maximus currently has an average rating of “Hold”.

Insider Activity

In other news, Director Jan Madsen sold 742 shares of Maximus stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director directly owned 20,795 shares of the company’s stock, valued at $1,502,438.75. The trade was a 3.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.80% of the stock is owned by corporate insiders.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.